TECH BUYER Dec 2020 - IDC PlanScape - Doc # EUR146000820

Digital Transformation for Patient Engagement in Pharma: The Landscape of Opportunities

By: Nino GiguashviliSenior Research Analyst, Silvia PiaiResearch Director, Europe


For companies planning on digital patient engagement initiatives, it is important to closely examine the whole spectrum of use cases to spot the opportunities and the key benefits therein. This IDC PlanScape offers a comprehensive framework for pharmaceutical companies to help them envision the broad landscape of digital patient engagement opportunities, navigate through them, identify critical success factors, and outline the "why, what, who, and how" to support in planning strategic investments in digital transformation for patient engagement.

"The pharmaceutical industry needs to break out from the traditional model that focuses on product journey and explore the opportunities emerging across patient journeys. The time is ripe for pharma to start planning and executing digital transformation programs for patient engagement, envisioning the opportunities within, around, and beyond the pill. Pharma has a unique opportunity now to establish its new brand on the digital patient engagement arena," said Nino Giguashvili, senior research analyst, IDC Health Insights Europe.

"As the pandemic accelerates the shift to digital engagement channels, European life sciences companies must ramp up their efforts to leverage ICT solutions and platforms to enable stronger engagement across the various touch points of the patient journey. The new 'patient engagement by design' approach will determine not only the requirements for the digital front door, but also for the underlying intelligence and infrastructure layers," said Silvia Piai, research director, IDC Health Insights Europe.



Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.

Related Links

Do you have questions about this document
or available subscriptions?

Contact Us